explore -WSS

explore

author：comprehensive 2025-10-01 00:07:15 - browse：7725

A new asthma treatment that could be administered just once every six months has succeeded in two Phase 3 trials, developer GlaxoSmithKline announced Tuesday.

The drug, depemokimab, is designed to treat asthma by targeting a protein called interleukin-5, or IL-5. The protein is linked to the type of inflammation found in most severe asthma cases, according to the pharma company.

Depemokimab hit its primary endpoints in the trials, reducing asthma attacks over a year’s time frame. The company didn’t disclose exact details from the SWIFT-1 and SWIFT-2 trials.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Marvel Studios reveals new trailer for 'The Marvels': Watch here

hotspot

WSS

Why health care costs have stayed mostly flat since 2010

Contact tracing may help avoid another lockdown. Can it work in the U.S.?

Can sheer will power keep patients alive in their dying hours?

Contact tracing may help avoid another lockdown. Can it work in the U.S.?

Why health care costs have stayed mostly flat since 2010

Humana’s Medicare Advantage lawsuit should be tossed, DOJ says

hotspot

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

Medical records are filled with copy

Review: 'Barbie' will hit you like a shot in the heart

Virginia high school admissions case could be legal follow

David Ricks of Eli Lilly: best biopharma CEO of 2023

Anesthesiologist group: stop taking Ozempic before surgery

Hospitals owned by private equity see complications spike 25%

Novavax promises a turnaround & Lilly roils the obesity market

Court strikes down limits on filming of police in Arizona

The high cost of giving birth even with insurance

Elizabeth Warren probes abortion access

focus

Prime Medicine, Myeloid Therapeutics clash over genome

Prime Medicine, Myeloid Therapeutics clash over genome

CRISPR gene editing developments we’re watching in 2024

Carvykti CAR

Why an extreme heat and wildfire smoke combination can be so dangerous

Russian special forces kill a gunman who broke into a private house near Moscow

leisure time

hotspot

hotspot

Wikipedia